Abstract
We have shown previously that the most common point mutation in the RBI gene in retinoblastoma tumours is a C→T transition and that the majority of these occur in CGAarg codons. As a result of this mutation, a TGAstop codon is generated directly. We have analysed the 14 CGAarg codons in the RB1 gene for mutations in 113 patients with bilateral retinoblastoma. At 6 of these sites, C→T mutations in CGA codons alter a restriction enzyme site which makes their identification relatively straightforward. It was necessary, however, to analyse the other 8 CGA codons using single-strand conformation polymorphism (SSCP) analysis. A total of 18 C→T mutations were found, which represents 16% of all patients. Of these 13 (73%) were at two particular CGA codons in exon 8 (codon 251) and exon 17 (codon 552). During the course of the SSCP analysis, mutations were identified in 7 other individuals. Thus, 20–25% of all mutations can be identified by a relatively quick survey of the CGA codons in the RB1 gene, which has important implications for genetic screening programmes. All of the mutations in the RB1 gene in these bilaterally affected patients would be predicted to result in the absence of a functional protein.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Vogel F: Genetics of retinoblastoma. Hum Genet 1979;52:1–54
Wiggs J, Nordenskjeld M, Yandell D, Rapaport J, Grondin V, Janson M, Werelius B, Petersen R, Craft A, Riedel K, Lieberfarb R, Walton D, Wilson W, Dryja TP: Prediction of the risk of hereditary retinoblastoma using DNA polymorphisms within the retinoblastoma gene. New Engl J Med 1988;318:151–157
Onadim ZO, Mitchell CD, Rutland PC, Buckle BG, Jay M, Hungerford JL, Harper K, Cowell JK: Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom. Arch Dis Child 1990;65:651–656
Mitchell CD, Nicolaides K, Kingston J, Hungerford J, Jay M, Cowell JK: Prental exclusion of hereditary retinoblastoma. Lancet 1988;i:826.
Onadim Z, Hungerford J, Cowell JK: Follow-up of retinoblastoma patients having prenatal and perinatal predictions for mutant gene carrier status using intragenic polymorphic probes from the RB1 gene. Br J Cancer 1992;65:711–716
Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779–784
Dunn JM, Phillips RA, Becker AJ, Gallie BL: Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988;241:1797–1800
Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL: Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol 1989,9:4596–4604.
Hogg A, Bia B, Onadim Z, Cowell JK: Molecular mechanisms of oncogenic mutations in tumours from patients with bilateral and unilateral retinoblastoma. Proc Natl Acad Sci USA 1993;90:7351–7355
Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie-Rosell A, Buckley EG, Dryja TP: Oncogenic point mutations in the human retinoblastoma gene: Their application to genetic counselling. New Engl J Med 1989;321:1689–1695
Blanquet V, Turleau C, Gross MS, Goossens M, Besmond C: Identification of germline mutations in the RB1 gene by denaturant gradient gel electrophoresis and polymerase chain reaction direct sequencing. Hum Mol Genet 1993;2:975–979
Hogg A, Onadim Z, Baird PN, Cowell JK: Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism, analysis and polymerase chain reaction sequencing. Oncogene 1992;7:1445–1451
Onadim Z, Hogg A, Cowell JK: Mechanisms of oncogenesis in patients with familial retinoblastoma. Br J Cancer 1993;68:958–964
Draper GJ, Sanders BM, Brownbill PA, Hawkins MM: Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br J Cancer 1992;66:211–219
Friend SH, Horowitz JM, Gerber MR, Wang XF, Bogenmann E, Li FP, Weinberg RA: Deletions of a DNA sequence in retinoblastomas and mesenchymal tumours: Organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 1987;84:9059–9063
McGee TL, Yandell DW, Dryja TP: Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene 1989;80:119–128
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
Knudson AG: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820–823
Kratzke RA, Hogg A, Otterson GA, Coxon AB, Geradts A, Cowell JK, Kaye FJ: Incomplete penetrance of familial retinoblastoma and benign retinal tumors associated with partial inactivation of the RB product. Oncogene 1994;9:1321–1326
Weir-Thompson E, Condie A, Leonard RCF, Presser J: A familial RB1 mutation detected by the HOT technique is homozygous in a second primary neoplasm. Oncogene 1991;6:2353–2356
Onadim Z, Hogg A, Baird PN, Cowell JK: Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci USA 1992;89:6177–6181
Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL: Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 1993;52:1122–1128
Hu Q, Dyson N, Harlow E: The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutation. EMBO J 1990;9:1147–1155
Kaye FJ, Kratzke RA, Gerster JL, Horowitz JM: A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 1990;87:6922–6926
Acknowledgements
BB is supported by a grant from the David Allen Retinoblastoma Fund.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cowell, J.K., Smith, T. & Bia, B. Frequent Constitutional C to T Mutations in CGA-Arginine Codons in the RB1 Gene Produce Premature Stop Codons in Patients with Bilateral (Hereditary) Retinoblastoma. Eur J Hum Genet 2, 281–290 (1994). https://doi.org/10.1159/000472372
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1159/000472372
Key Words
This article is cited by
-
The management of retinoblastoma
Oncogene (2018)
-
Rapid detection of RB1 recurrent mutations in retinoblastoma by ARMS-PCR
Journal of Genetics (2016)
-
Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
BMC Cancer (2015)
-
Genetic screening in patients with Retinoblastoma in Israel
Familial Cancer (2015)
-
Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma
Tumor Biology (2015)
